论文部分内容阅读
肿瘤乏氧代谢与肿瘤的侵袭性及预后不良相关,碳酸酐酶Ⅸ(carbonic anhydraseⅨ,CAⅨ)是一个内生性乏氧标志,近年来对CAⅨ的研究发现,CAⅨ的表达与非小细胞肺癌(NSCLC)患者的生存期、肿瘤侵袭性等因素相关,其高表达可以作为预后不良的预测因素。CAⅨ可以作为治疗的靶点,其抑制剂已经被发现具有抗肿瘤作用,但对肺癌的作用尚需进一步研究。该文主要对CAⅨ及其在NSCLC中的研究进展作一综述。
Tumor hypoxia metabolism is associated with tumor aggressiveness and poor prognosis. Caronic anhydrase IX (CAIX) is an endogenous hypoxia marker. In recent years, studies on CA IX found that the expression of CA IX is associated with non-small cell lung cancer (NSCLC ) Patients with survival, tumor invasion and other factors related to its high expression can be used as a prognostic factor for poor prognosis. CAIX can be used as a therapeutic target, the inhibitor has been found to have anti-tumor effect, but the role of lung cancer needs further study. This article mainly reviews the research progress of CAIX and its application in NSCLC.